Join SMi at their 6th annual Pharmaceutical Portfolio & Product Life-Cycle Management that is a well established meeting ground for managers and directors who are faced with the task of managing the pipeline.

In the close up environment that our conferences provide, you can expect to discuss with some of the leading professionals in the field the best way to approach this difficult task. In a showcase of effective approaches from many of the largest pharmaceutical companies, you can be sure to learn much of value to yourself, and to your organization.

Take the opportunity of our SPECIAL OFFER - £999

Make sure you don't miss this conference with over 10 major pharmaceutical companies represented by our speakers alone, delegates can be sure to have the opportunity to meet major players in the industry and discuss:

Portfolio management: Integrated approaches to R&D
Mellor Hennessy, Global Portfolio Strategist, AstraZeneca

Project and portfolio risk analysis
Kimber Hardy, Head of Valuation and Analysis, Portfolio Management , Merck Serono

Holistic portfolio management at Bayer Healthcare Pharmaceuticals
Alessio Merlin, Director, Strategic Planning , Bayer Schering Pharma

Life-cycle Management - Applied case study
Marie Bernasconi, Global Program Team Director, Novartis

Early stage strategies and intellectual property
Julie Barrett-Major, Director of Intellectual Property, Norgine Ltd

For more information and to download the brochure visit here.

Source:
SMi Group